Symbol="VCNX"
AssetType="Common Stock"
Name="Vaccinex Inc"
Description="Vaccinex, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company is headquartered in Rochester, New York."
CIK="1205922"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1895 MOUNT HOPE AVE, ROCHESTER, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="18951700"
EBITDA="-20101000"
PERatio="None"
PEGRatio="None"
BookValue="0.044"
DividendPerShare="0"
DividendYield="0"
EPS="-0.42"
RevenuePerShareTTM="0.018"
ProfitMargin="0"
OperatingMarginTTM="-24.6"
ReturnOnAssetsTTM="-1.102"
ReturnOnEquityTTM="-2.171"
RevenueTTM="825000"
GrossProfitTTM="-13704000"
DilutedEPSTTM="-0.42"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="699.37"
PriceToBookRatio="5.53"
EVToRevenue="566.13"
EVToEBITDA="-1.476"
Beta="0.969"
num_52WeekHigh="1.5"
num_52WeekLow="0.29"
num_50DayMovingAverage="0.384"
num_200DayMovingAverage="0.493"
SharesOutstanding="65351000"
DividendDate="None"
ExDividendDate="None"
symbol="VCNX"
open="0.31"
high="0.32"
low="0.29"
price="0.29"
volume="76127.00"
latest_trading_day="2023-07-20"
previous_close="0.31"
change="-0.02"
change_percent="-5.7524%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="87"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="13"
Volume_recent_avg="160845"
Change_recent_avg="0.01"
Delta_recent_avg="0.03"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-0.77"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="13"
Aroon_momentum_negative="87"
image_negative_thumbnail_id_1="141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_negative_thumbnail_id_2="1097"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0130.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="635"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
